10x Genomics, Inc. Restructuring Costs and Asset Impairment Charges
10x Genomics, Inc. (TXG) reported Restructuring Costs and Asset Impairment Charges of $1.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-02-13
- 10x Genomics, Inc. restructuring costs and asset impairment charges for fiscal 2025 was $1.25M.
- 10x Genomics, Inc. restructuring costs and asset impairment charges for fiscal 2024 was $0.00.
- 10x Genomics, Inc. restructuring costs and asset impairment charges for fiscal 2023 was $0.00.
| Period end | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|
| 2025-12-31 | $1.25M 10-K · filed 2026-02-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-13 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 |